What FIECON does

FIECON is a UK-headquartered health economics and outcomes research (HEOR) consultancy founded in 2015, providing outcomes research, economic modelling, health technology assessment (HTA) submissions, value communication, pricing and reimbursement strategy, and real-world evidence services to pharmaceutical, biotechnology, and medical technology companies across global markets. The firm pairs traditional consulting expertise with a proprietary digital platform layer, including a Private AI/LLM platform with bespoke agents (notably an AI Objection Handler for payer negotiation simulation), a Model Builder that automates Excel-based economic models, an NMA Builder for network meta-analyses using NICE TSD-co-authored R packages, and interactive tools such as the SLR Dashboard, Market Access Hub, Reimbursement Tracker, Value Platform, Interactive BIM, Payer Value Story, and Early Value Assessment.

FIECON operates a sales-led B2B professional services model with project-based, quote-based engagements delivered directly to life sciences clients. Reported performance signals include a 96% success rate across 75+ global HTA submissions (100% in rare disease), 30+ HTA submissions led personally by Executive Director Holly Guy, and quantified AI workflow savings of 50-80% on screening and 95%+ on data extraction. In April 2025 FIECON was integrated into Herspiegel, and in April 2026 it became part of Acumetis, a merged platform of five life sciences consultancies backed by private equity firm DFW Capital, employing 350+ specialists across 15+ countries and serving 150+ life sciences organizations.

Name

FIECON

Legal name

FIECON Ltd.

Website

https://fiecon.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

FIECON is a UK-based health economics consultancy that delivers HEOR, HTA submission, economic modelling, pricing and market access services to pharma, biotech, and med tech clients globally, supported by proprietary AI-powered digital platforms. Now operating under the Acumetis platform.

Ownership category

akta.pro rank

Product category

Health Economics & Market Access Consulting

NAICS

Other Scientific and Technical Consulting Services (54169), Custom Computer Programming Services (541511), Marketing Research and Public Opinion Polling (541910)

SIC

Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Market Access, Pricing & Reimbursement (Evidence Generation) FSP (HLAGAOAN)

akta.pro secondary industries

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB)

Keywords

• Health economics consulting
• Market access services
• Health technology assessment
• Outcomes research
• Pharmaceutical consulting

Headquarters

HQ city

Saint Albans

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Health Economics Consultancy Services: Professional consulting services in health economics, outcomes research, economic modelling, HTA submissions, value communication, and market access strategy. Services are project-based and tailored to client needs across the product lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

FIECON is a health economics and outcomes research (HEOR) consultancy that delivers systematic literature reviews, meta-analyses, economic modelling (Markov to discrete event simulations), HTA submissions (NICE, SMC, AWMSG), pricing and reimbursement strategy, value communication, and real-world evidence services to pharmaceutical, biotech, and med tech companies. The consultancy is augmented by a suite of proprietary digital platforms including a Private AI/LLM platform, Model Builder, NMA Builder, SLR Dashboard, Market Access Hub, Reimbursement Tracker, Value Platform, Interactive BIM, Payer Value Story, and Early Value Assessment tools that automate workflows and enhance HTA submission quality.

Product overview

FIECON is a health economics and outcomes research (HEOR) consultancy that offers a hybrid model combining expert consulting services with proprietary technology tools. The core service offerings include Outcomes Research, Economic Modelling, Health Technology Assessment, Value Communication, Pricing & Reimbursement, and Real World Evidence. These are complemented by a suite of digital solutions including the SLR Dashboard, Reimbursement Tracker, Market Access Hub, Interactive BIM, Payer Value Story, and Early Value Assessment (EVA), as well as technology platforms such as the Private AI Platform, Model Builder, NMA Builder, and Value Platform. FIECON joined the Herspiegel Group in April 2025 and is now part of Acumetis, a global life sciences commercialization company formed by merging five specialist consultancies.

Differentiator

Problem solved

Functional benefit

Products and services

• Outcomes Research Systematic reviews, meta-analyses, and patient-level data analyses for health economic evidence generation. Service delivers all aspects of evidence synthesis with high accuracy and quality for pharmaceutical, biotech, and med tech clients.
• Economic Modelling
• Health Technology Assessment
• Value Communication
• Pricing & Reimbursement
• Real World Evidence
• SLR Dashboard
• Reimbursement Tracker
• Market Access Hub
• Interactive BIM
• Payer Value Story
• Early Value Assessment (EVA)
• Private AI Platform
• Model Builder
• NMA Builder
• Value Platform

Quantifiable outcome

• 50% time savings in SLR screening with hybrid AI workflow
• +7 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature11 records

Partnerships

Two partnerships are on record, tiered core.

• Acumetis (Parent Entity)coreOthers · 14 April 2026FIECON merged with Herspiegel, Adivo Associates, Decisive Consulting, and Sixsense Strategy Group to form Acumetis, a global life sciences commercialization company. The unified business employs over 350 specialists globally, supports more than 150 life sciences organizations, and is backed by private equity firm DFW Capital.
• Pharma BPcoreStrategic or Co-development PartnerFIECON has partnered with Pharma BP, a life sciences consultancy with specialty expertise in the Middle East and Africa (MEA) region. The partnership enables FIECON to offer comprehensive HTA support services for Saudi Arabia, including pricing strategy, economic modelling, HTA strategy, submission dossier preparation, and post-submission negotiations. The collaboration has achieved 96% success rate across 75+ global HTA submissions and 100% success rate in rare disease HTA submissions.

Scale indicators10 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Evidera (PPD / Thermo Fisher Scientific): Evidera is a dedicated HEOR, market access, real-world evidence and HTA consultancy — historically part of PPD and now within Thermo Fisher — and is one of FIECON's closest direct competitors in HTA submissions, economic modelling and value communication for life sciences clients.
• CBPartners: CBPartners is a specialized market access, pricing and HEOR consultancy serving pharma and biotech, with strong overlap with FIECON in HTA, payer engagement and value demonstration work.
• BresMed Health Solutions: BresMed is a UK-headquartered HEOR and market access consultancy focused on HTA submissions (notably NICE), economic modelling and systematic reviews — directly comparable to FIECON's core service lines.
• Mtech Access (Avalere Health): Mtech Access is a UK-based market access and HEOR consultancy, now part of Avalere Health, offering HTA submissions, economic modelling and payer engagement — directly comparable to FIECON's offering and customer base.
• Wickenstones: Wickenstones is a specialist HEOR, market access and pricing consultancy working with pharma and biotech, directly comparable to FIECON in scope of services and life sciences client base.
• Precision Health Economics (Precision Medicine Group): Precision Health Economics is a dedicated HEOR, market access and pricing consultancy within Precision Medicine Group, directly comparable to FIECON in economic modelling, HTA and value communication.
• Putnam Associates: Putnam Associates is a strategic consulting firm to pharma and biotech with deep HEOR, market access and pricing expertise — closely comparable to FIECON's strategic advisory offerings.

Broad incumbents

• IQVIA: IQVIA is a global CRO and life sciences services giant with a sizable HEOR and real-world evidence practice, competing with FIECON on large enterprise HEOR mandates and bundled commercial services.
• ICON plc: ICON plc is a global CRO with significant HEOR and market access capabilities via legacy PRA Health Sciences and dedicated advisory teams — competes with FIECON on integrated clinical-to-commercial engagements.
• Parexel: Parexel is a global CRO with established market access, HEOR and pricing consulting capabilities serving large pharma — competes with FIECON on enterprise HEOR engagements and integrated commercialization programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fiecon-limited/mycompany
• Instagraminstagram.com/fieconhealtheconomics
• Xx.com/fieconteam

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FIECON